Department of Medicine and Surgery, University of Parma, Parma, Italy.
Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Int J Clin Pract. 2022 May 29;2022:2887312. doi: 10.1155/2022/2887312. eCollection 2022.
Pulse oximetry screening is a safe, feasible test, effective in identifying congenital heart diseases in otherwise well-appearing newborns. Uncertainties still persist on the most effective algorithm to be used and the timing of screening. The aim of this study was to evaluate the role of the pulse oximetry screening associated with the peripheral perfusion index performed in the first 24 hours of life for the early detection of congenital heart diseases and noncongenital heart diseases in the newborns.
A prospective observational cohort study was conducted. The enrollment criteria were as follows: term newborns with an APGAR score >8 at 5 minutes. The exclusion criteria were as follows: clinical signs of prenatal/perinatal asphyxia or known congenital malformations. Four parameters of pulse oximetry screening were utilized: saturation less than 90% (screening 1), saturation of less than 95% in one or both limbs (screening 2), difference of more than 3% between the limbs (screening 3), and preductal peripheral perfusion index or postductal peripheral perfusion index below 0.70 (screening 4). The likelihood ratio, sensibility, specificity, and positive and negative predictive values for identification of congenital heart diseases or noncongenital heart diseases (suspicion of perinatal infection and any respiratory diseases) were evaluated.
The best predictive results for minor congenital heart disease were obtained combining screening 3 and screening 4 ( (1) = 15,279; < 0.05; OR = 57,900 (9,465-354,180)). Screening 2, screening 3, and screening 4 were predictive for noncongenital heart diseases ( (1) = 11,550; < 0.05; OR = 65,744 (10,413-415,097)). Combined screenings 2-4 were predictive for both congenital heart disease and noncongenital heart disease ( (1) = 22,155; < 0.05; OR = 117,685 (12,972-1067,648)).
Combining peripheral saturation with the peripheral perfusion index in the first 24 hours of life shows a predictive role in the detection of minor congenital heart diseases and neonatal clinical conditions whose care needs attention.
脉搏血氧饱和度筛查是一种安全、可行的检测方法,可有效识别外观正常的新生儿中的先天性心脏病。但目前对于最有效的检测算法和筛查时间仍存在不确定性。本研究旨在评估在新生儿生命的头 24 小时内进行脉搏血氧饱和度筛查,同时检测外周灌注指数,对早期发现先天性心脏病和非先天性心脏病的作用。
本研究采用前瞻性观察性队列研究。纳入标准为:APGAR 评分 5 分钟时≥8 分的足月新生儿。排除标准为:产前/围生期窒息的临床体征或已知的先天性畸形。共采用 4 项脉搏血氧饱和度筛查参数:饱和度<90%(筛查 1)、一个或两个肢体饱和度<95%(筛查 2)、肢体之间差异>3%(筛查 3)、未梢动脉外周灌注指数或末梢后动脉外周灌注指数<0.70(筛查 4)。评估了对先天性心脏病或非先天性心脏病(疑似围生期感染和任何呼吸系统疾病)的识别的阳性似然比、敏感性、特异性、阳性和阴性预测值。
筛查 3 和筛查 4 联合检测对小的先天性心脏病具有最佳的预测结果( (1) = 15,279;<0.05;OR = 57,900(9,465-354,180))。筛查 2、筛查 3 和筛查 4 对非先天性心脏病具有预测价值( (1) = 11,550;<0.05;OR = 65,744(10,413-415,097))。联合筛查 2-4 对先天性心脏病和非先天性心脏病均具有预测价值( (1) = 22,155;<0.05;OR = 117,685(12,972-1067,648))。
在新生儿生命的头 24 小时内结合外周饱和度和外周灌注指数的检测,对小的先天性心脏病和需要关注的新生儿临床情况具有预测作用。